Global Dna Encoded Library: Transformation Of Drug R&d And Deliver New Treatments To Patients

By Author: colin
Total Articles: 166
Comment this article

DNA encoded libraries (DELs) provide a powerful technique for discovering new lead compounds for drug development. Traditional high-throughput screening methods evaluate libraries containing millions of pre-made small molecules for biological activity. While powerful, these approaches are limited by the chemical diversity present in the screening libraries. DELs address this limitation by encoding vast libraries of small molecules directly into DNA in a way that preserves the link between genotype and phenotype.

Encoding Chemical Diversity In DNA

In a DEL, Global DNA Encoded Libraries is used to represent billions of diverse small molecules. Short DNA oligonucleotides encode the synthetic route to make each corresponding small molecule. Each DNA sequence contains the information required to synthesize a unique molecule. By encoding vast numbers of potential molecules in DNA rather than pre-making them, DELs can explore exponentially larger regions of chemical space than is possible with traditional screening collections. The encoded molecules only need to be synthesized if a "hit" is identified, dramatically improving ...
... the efficiency of screening vast libraries.

Synthesizing Molecules From Their DNA Codes

When a "hit" DNA sequence is identified from screening, the encoded small molecule can then be chemically synthesized based on the instructions embedded in its DNA code. Various DNA-directed synthesis techniques have been developed that leverage the sequence information to guide combinatorial synthesis from DNA-encoded building blocks. After synthesis from its DNA code, the actual small molecule can then be isolated and studied further for potency and selectivity. The ability to access molecules only as needed from their genetic representation is a major advantage of DEL approaches.

Screening Dels To Discover Leads

DELs are screened using the same techniques as traditional small molecule libraries, such as biochemical assays, cellular assays or phenotypic screens. A DNA encoded libraries is introduced to a biological system and molecules that show desired activity, such as binding a target protein or modifying a cellular phenotype, can be identified. The DNA encoding these "hit" molecules remains associated, allowing their recovery following sequencing and synthesis from their DNA codes. Screening DELs has been demonstrated for a wide range of targets from proteases to protein-protein interactions and phenotypes such as antibacterial activity.

Global Efforts In DEL Development And Application

Given their ability to access far greater regions of chemical space, DNA-encoded libraries are being actively pursued around the world both by large pharmaceutical companies and academic labs for drug discovery applications. Below are some examples of notable global efforts:

- Companies like Amgen, Astex Pharmaceuticals, GlaxoSmithKline and others have invested heavily in developing proprietary DEL platforms and applying them to discover leads against diverse targets.

- The University of Oxford established one of the earliest academic DEL platforms, encoding billions of small molecules for use in hit discovery projects in collaboration with various partners.

- In the United States, universities including UCLA, MIT, UC San Diego have been leveraging DELs in collaborative projects to probe new biology and identify starting points for therapeutics.

- China has made DELs a priority, with programs launched at Shanghai Institute of Materia Medica, ShanghaiTech University and other top Chinese institutions working to pioneer DEL techniques.

- DNA-encoded compound libraries are also actively being applied in Japan, with research programs employing this technology for drug discovery at universities including Kyoto University and Osaka University Medical School.

While still an emerging technology, DNA-encoded libraries have shown great potential to access exponentially larger regions of chemical space than traditional screening libraries for accelerated hit and lead discovery. Global collaborations between and academia will be important to fully realize the potential of this powerful approach.

DNA-encoded libraries leverage the encoded of vast numbers of small molecules in DNA to explore exponentially larger regions of chemical space than is possible with traditional screening collections. By preserving the link between genotype and phenotype, DELs allow molecules to be synthesized as needed from their genetic representations when a hit is identified from biological screening. Global efforts at top pharmaceutical companies and academic labs are actively developing DEL platforms and applying them to identify starting points for drug development. DELs show significant promise as an accelerant for early-stage drug discovery.

Get more insights on this topic: https://fortunetelleroracle.com/news/global-dna-encoded-libraries-a-revolutionary-approach-to-drug-discovery-919716

About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it